Goldman Sachs Says Curing Diseases May Not Be Economically Viable
A leaked report has stated what many in the health industry have whispered privately; there is a lot less money in curing people than in long-term management of disease. The issue is brought into focus by the possibility of a gene therapy that could soon cure a
